Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03193437
Title Selinexor in Patients With Advanced Thymic Epithelial Tumor Progressing After Primary Chemotherapy
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Georgetown University
Indications

thymic carcinoma

thymoma

Therapies

Selinexor

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Georgetown Lombardi Comprehensive Cancer Center Washington District of Columbia 20007 United States Details
John Theurer Cancer Center - Hackensack University Medical Center Hackensack New Jersey 07601 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field